Stoke Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Stoke Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 29% to $8,780,000. Profit margin reached -1192%. Total operating expenses were $123,553,000.
Profit Margin
| 2017 | 0 | -5.55M | |
|---|---|---|---|
| 2018 | 0 | -12.52M | |
| 2019 | 0 | -28.52M | |
| 2020 | 0 | -50.61M | |
| 2021 | 0 | -84.71M | |
| 2022 | 12.40M | -93.11M | -750.58% |
| 2023 | 8.78M | -104.69M | -1192.47% |
STOK Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 8.78M | 12.40M | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 3.53M | 2.23M | 1.92M | 450K | 0 | 113K |
Gross profit | 8.78M | 8.87M | -2.23M | -1.92M | -450K | 0 | -113K |
Operating exp. | |||||||
Research and development | 82.23M | 77.83M | 54.16M | 32.19M | 23.76M | 8.37M | 3.59M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 123.55M | 116.76M | 86.06M | 53.04M | 35.67M | 12.78M | 5.55M |
Operating income | -114.77M | -104.35M | -86.06M | -53.04M | -35.67M | -12.78M | -5.55M |
Other income (expenses), net | 10.07M | 3.28M | 260K | 801K | 3.35M | -10K | -4K |
Income before tax | -104.69M | -101.06M | -85.80M | -52.24M | -32.32M | -12.52M | -5.55M |
Income tax expense | 0 | -7.95M | -1.09M | -1.63M | -3.80M | 260K | 0 |
Net income | -104.69M | -93.11M | -84.71M | -50.61M | -28.52M | -12.52M | -5.55M |
Earnings per share | |||||||
Basic EPS | -2.38 | -2.39 | -2.31 | -1.51 | -1.59 | -0.53 | -0.43 |
Diluted EPS | -2.38 | -2.39 | -2.31 | -1.51 | -1.59 | -0.53 | -0.43 |
| Data source | Data source | Data source | Data source | Data source |